Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism
Myelination, which occurs predominantly postnatally and continues throughout life, is important for proper neurologic function of the mammalian central nervous system (CNS). We have previously demonstrated that the combination therapy of fingolimod (FTY720) and transplanted neural stem cells (NSCs)...
Main Authors: | Yuan Zhang, Xin-Yu Lu, Ze-Qin Ye, Bogoljub Ciric, Cun-Gen Ma, Abdolmohamad Rostami, Xing Li, Guang-Xian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2019.00014/full |
Similar Items
-
Corrigendum: Combination therapy with fingolimod and neural stem cells promotes functional myelination in vivo through a non-immunomodulatory mechanism
by: Yuan Zhang, et al.
Published: (2022-12-01) -
Unraveling Myelin Plasticity
by: Giulia Bonetto, et al.
Published: (2020-06-01) -
Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
by: Edward L. Hogan, et al.
Published: (2013-08-01) -
Editorial: Physiology of Myelin Forming Cells, From Myelination to Neural Modulators
by: Marion Baraban, et al.
Published: (2019-10-01) -
Endothelin signalling mediates experience-dependent myelination in the CNS
by: Matthew Swire, et al.
Published: (2019-10-01)